logo-loader
Crescita Therapeutics Inc

Crescita Therapeutics Signs Pliaglis Out-Licensing Agreement with Cantabria Labs

Crescita Therapeutics (TSE:CTX-OTC:CFFTF) President and CEO Serge Verreault joined Steve Darling from Proactive Investors Vancouver to discuss the dermatology company signing a big deal with Cantabria Labs for their product Pliaglis. 

Verreault telling Proactive how much that is worth to the company and which markets the deal opens up.

Quick facts: Crescita Therapeutics Inc

Price: $0.85

Market: TSX
Market Cap: $17.86 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks flat as a pancake but CROP shares jump on first...

Cannabis stocks cruised into Friday flat as a pancake across North American markets. Buds today were CROP Infrastructure Corp (CSE:CROP) (OTCMKTS:CRXPF), True Leaf Brands Inc (CSE:MJ) (OTCMKTS:TRLFF), while the duds were TerrAscend Corp (CSE:TER) (OTCMKTS:TRSSF),...

2 days, 11 hours ago

2 min read